1. Home
  2. CLPS vs COEP Comparison

CLPS vs COEP Comparison

Compare CLPS & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLPS
  • COEP
  • Stock Information
  • Founded
  • CLPS 2005
  • COEP 2017
  • Country
  • CLPS Hong Kong
  • COEP United States
  • Employees
  • CLPS N/A
  • COEP N/A
  • Industry
  • CLPS Computer Software: Prepackaged Software
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CLPS Technology
  • COEP Health Care
  • Exchange
  • CLPS Nasdaq
  • COEP Nasdaq
  • Market Cap
  • CLPS 35.1M
  • COEP 32.4M
  • IPO Year
  • CLPS 2018
  • COEP N/A
  • Fundamental
  • Price
  • CLPS $1.25
  • COEP $11.54
  • Analyst Decision
  • CLPS
  • COEP
  • Analyst Count
  • CLPS 0
  • COEP 0
  • Target Price
  • CLPS N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • CLPS 21.4K
  • COEP 136.7K
  • Earning Date
  • CLPS 03-04-2025
  • COEP 03-25-2025
  • Dividend Yield
  • CLPS 9.85%
  • COEP N/A
  • EPS Growth
  • CLPS N/A
  • COEP N/A
  • EPS
  • CLPS N/A
  • COEP N/A
  • Revenue
  • CLPS $142,812,726.00
  • COEP N/A
  • Revenue This Year
  • CLPS N/A
  • COEP N/A
  • Revenue Next Year
  • CLPS N/A
  • COEP N/A
  • P/E Ratio
  • CLPS N/A
  • COEP N/A
  • Revenue Growth
  • CLPS N/A
  • COEP N/A
  • 52 Week Low
  • CLPS $0.68
  • COEP $2.31
  • 52 Week High
  • CLPS $1.70
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • CLPS 60.32
  • COEP 59.40
  • Support Level
  • CLPS $1.20
  • COEP $8.65
  • Resistance Level
  • CLPS $1.28
  • COEP $13.70
  • Average True Range (ATR)
  • CLPS 0.08
  • COEP 2.11
  • MACD
  • CLPS 0.00
  • COEP -0.24
  • Stochastic Oscillator
  • CLPS 78.89
  • COEP 61.22

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: